课题基金 / 基金详情

Investigation of immunologic heterogeneity of primary head and neck cancer and its cervical metastases.

Investigation of immunologic heterogeneity of primary head and neck cancer and its cervical metastases.
原发性头颈癌及其颈部转移的免疫异质性研究。
批准号:
61480359
负责人:
ISHIKAWA Takeru
金额:
$3.01万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1986
资助国家:
日本
项目状态:
已结题
起止时间:
1986 至 1988

项目摘要

项目成果

ISHIKAWA Takeru的其他基金

相似基金

相关文献

中文摘要
翻译
采用细胞毒性淋巴细胞(CL)敏感性检测方法,检测了12例头颈部肿瘤原发灶和颈淋巴结转移灶的抗原性差异。采用自体混合淋巴细胞肿瘤细胞培养(MLTC)和重组白介素2(rIL-2)诱导细胞毒作用。本研究中使用的效应细胞由OKT3+8+和OKT3+4+亚群组成。它们的细胞毒性质与淋巴因子激活的杀伤细胞(LAK细胞)不同。12例患者中有7例(58.3%)观察到自体原代肿瘤细胞(CLP)刺激的CLS的细胞毒作用。12例患者中有4例(33.3%)观察到转移瘤细胞(CLM)刺激的CLS的细胞毒作用。在成功诱导CLP和CLM的情况下,进行交叉反应试验和冷靶抑制试验。这些结果表明,转移部位的免疫原性降低,原发和转移的肿瘤细胞对自体CL的敏感性不同。
英文摘要
Antigenic differences between primary tumors and their cervical lymph node metastases of 12 patients with head and neck cancers were examined by measuring their sensitivity to cytotoxic lymphocytes(CL). Cytotoxicity was induced by autologous mixed lymphocyte tumor cell culture (MLTC), and further cultivation with recombinant interleukin-2(rIL-2). The effector cells which were used in this study consisted of OKT3+8+ and OKT3+4+ subpopultions. Their cytotoxic nature was different from lymphokine activated killer cell (LAK cell) activity. Cytotoxicity of CLs stimulated by autologous primary tumor cells(CLp) was observed in 7 out of 12 patients(58.3%). In contrast, cytotoxicity of CLs stimulated by metastatic tumor cells (CLm) was observed in 4 out of 12 patients (33.3%). In the cases in which both CLp and CLm were successfully induced, cross-reactivity tests and cold target inhibition tests were performed. These results suggested that a reduction in immunogeneicity had occurred at the metastatic site, and sensitivity against autologous CL was different between primary and metastatic tumor cells.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Takeru Ishikawa.;Tsutomu Ikawa;Masao Eura,;Masao Eura,;Tadasuke Fukiage,;Keisuke Masuyama.: Acta Otolaryngol(Stockh). (1989)
Takeru Ishikawa.;Tsutomu Ikawa;Masao Eura,;Masao Eura,;Tadasuke Fukiage,;Keisuke Masuyama.:Acta Otolaryngol(Stockh)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Combination therapy for head and neck cancer with CTL induced in vitro and low dose of anticancer drugs followed by iradiation.
    • 批准号:
      06454490
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.1万
    • 财政年份:
      1994
    • 负责人:
      ISHIKAWA Takeru
    • 依托单位:
    Study on induction of autologous CTL by mixed culture with allogeneic tumor cells.
    • 批准号:
      02454397
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $3.52万
    • 财政年份:
      1990
    • 负责人:
      ISHIKAWA Takeru
    • 依托单位:
    海外基金